Sep 30, 2026
There is no universally accepted formula for measuring company-specific risk, yet the treatment of that risk can have a significant effect on a valuation conclusion. In this episode, Alex Partin and Josh Shilts examine the company-specific risk premium and consider where the economic effects of subject company...
Sep 3, 2026
Many valuation reports include all the required sections but still leave readers asking one question: How did you get to that conclusion? Valuation experts Bethany Hearn and Dr. Victor Jarosiewicz discuss the "missing link" problem in valuation reporting and explain how practitioners can create reports that...